Seres Therapeutics Announces FDA Acceptance of Biologics License Application for Investigational Microbiome Therapeutic SER-109 for Recurrent C. Difficile Infection for Priority Review Read more
Health Canada approves KERENDIA (finerenone) as an adjunct to standard of care therapy in adults with chronic kidney disease (CKD) and type 2 diabetes (T2D) Read more
CytoReason Announces Expanded Collaboration Deal with Pfizer to Deliver AI for Drug Discovery and Development Read more
WHO Expands Recommendation for Veklury (Remdesivir) to Patients With Severe Disease in Latest Update to COVID-19 Guideline Read more
Mallinckrodt Receives FDA Approval for Terlivaz (terlipressin) for injection for the Treatment of Hepatorenal Syndrome (HRS) Read more
Gatehouse Bio Extends Its Partnership with AstraZeneca to Develop RNA Therapeutics for Heart Failure Read more
FDA Grants Breakthrough Therapy Designation to Pfizer’s Group B Streptococcus Vaccine Candidate to Help Prevent Infection in Infants Via Immunization of Pregnant Women Read more
FDA approves the first treatment option for generalized pustular psoriasis flares in adults Read more